News & Perspective

Mar 14, 2017

Mar 14, 2017

Stewardship / Resistance Scan for Mar 14, 2017

Antibiotic misconceptions
Sexual spread of resistant bacteria
New gram-negative antibiotic

Jun 28, 2016

Jun 28, 2016

News Scan for Jun 28, 2016

Saudi MERS cases
2009 H1N1 origins in Mexico
WHO health emergency head
Strategic National Stockpile report

Nov 10, 2015

Nov 10, 2015

News Scan for Nov 10, 2015

More dengue cases in Hawaii
New CSL flu vaccine division

May 12, 2015

May 12, 2015

News Scan for May 12, 2015

Pertussis prevention
Public health R & D
Avian influenza outbreaks

Oct 27, 2014

Oct 27, 2014

CSL-Novartis deal includes US cell-based flu vaccine plant

The $275 million deal will make the company the second leading player in the $4 billion global flu vaccine market.

Feb 14, 2013

Feb 14, 2013

Euro studies show flu vaccine working best against type B

(CIDRAP News) – New European studies reported today in Eurosurveillance suggest that this year's influenza vaccine is providing good protection against influenza B viruses but only moderate protection against type A—findings more or less consistent with earlier results in the United States.

Pages

Sort Results

 

Narrow results

by country

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3M Gilead 
Grant support for ASP provided by

  Become an underwriter»